However, magnitude of weight loss difference may not be clinically significant
FRIDAY, Oct. 20, 2023 (HealthDay News) — Early-stage chronic kidney disease has a negative impact on short-term weight loss outcomes after bariatric metabolic surgery, according to a study published online Oct. 10 in Obesity Surgery.
João Pereira, from the School of Medicine and Biomedical Sciences at the University of Porto in Portugal, and colleagues evaluated the impact of kidney dysfunction on weight loss outcomes after bariatric metabolic surgery. The analysis included 127 participants undergoing gastric bypass with preoperative evaluation, as well as assessment at six and 12 months after surgery.
The researchers found that after surgery, the mean body mass index was 27.7 kg/m2 at six months and 25.0 kg/m2 at 12 months versus 39.6 kg/m2 before surgery. In patients with a preoperative estimated glomerular filtration rate less than the 25th percentile, the percent of total weight loss was lower (34.4 versus 39.4 at 12 months). For preoperative creatinine clearance rate, proteinuria, or albuminuria, there were no significant correlations noted between weight loss metrics.
“These findings, if confirmed over longer period, suggest that patients with obesity and concomitant early-stage (G2) deterioration of kidney function can still achieve satisfactory weight loss outcomes after bariatric metabolic surgery, while potentially benefiting from renal function improvements as previously reported,” the authors write.
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Early Complications Common in Older Kidney Transplant Recipients
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI
Frailty Linked to Incident Cognitive Decline in Men With CKD
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD
Recommendations Updated for Management of Anemia in CKD
More Advanced CKM Syndrome Linked to Worse Cardiovascular Health
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes